LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis

Supplemental Digital Content is available in the text. Rationale: The HDL (high-density lipoprotein)-mediated stimulation of cellular cholesterol efflux initiates macrophage-specific reverse cholesterol transport (m-RCT), which ends in the fecal excretion of macrophage-derived unesterified cholesterol (UC). Early studies established that LDL (low-density lipoprotein) particles could act as efficient intermediate acceptors of cellular-derived UC, thereby preventing the saturation of HDL particles and facilitating their cholesterol efflux capacity. However, the capacity of LDL to act as a plasma cholesterol reservoir and its potential impact in supporting the m-RCT pathway in vivo both remain unknown. Objective: We investigated LDL contributions to the m-RCT pathway in hypercholesterolemic mice. Methods and Results: Macrophage cholesterol efflux induced in vitro by LDL added to the culture media either alone or together with HDL or ex vivo by plasma derived from subjects with familial hypercholesterolemia was assessed. In vivo, m-RCT was evaluated in mouse models of hypercholesterolemia that were naturally deficient in CETP (cholesteryl ester transfer protein) and fed a Western-type diet. LDL induced the efflux of radiolabeled UC from cultured macrophages, and, in the simultaneous presence of HDL, a rapid transfer of the radiolabeled UC from HDL to LDL occurred. However, LDL did not exert a synergistic effect on HDL cholesterol efflux capacity in the familial hypercholesterolemia plasma. The m-RCT rates of the LDLr (LDL receptor)-KO (knockout), LDLr-KO/APOB100, and PCSK9 (proprotein convertase subtilisin/kexin type 9)-overexpressing mice were all significantly reduced relative to the wild-type mice. In contrast, m-RCT remained unchanged in HAPOB100 Tg (human APOB100 transgenic) mice with fully functional LDLr, despite increased levels of plasma APO (apolipoprotein)-B–containing lipoproteins. Conclusions: Hepatic LDLr plays a critical role in the flow of macrophage-derived UC to feces, while the plasma increase of APOB-containing lipoproteins is unable to stimulate m-RCT. The results indicate that, besides the major HDL-dependent m-RCT pathway via SR-BI (scavenger receptor class B type 1) to the liver, a CETP-independent m-RCT path exists, in which LDL mediates the transfer of cholesterol from macrophages to feces.

[1]  Richard G. Lee,et al.  Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[2]  E. Fisher,et al.  HDL and Reverse Cholesterol Transport. , 2019, Circulation research.

[3]  A. Grefhorst,et al.  The TICE Pathway: Mechanisms and Lipid-Lowering Therapies. , 2019, Methodist DeBakey cardiovascular journal.

[4]  A. Tall Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation. , 2018, Atherosclerosis.

[5]  M. Jauhiainen,et al.  Altered HDL Remodeling and Functionality in Familial Hypercholesterolemia. , 2018, Journal of the American College of Cardiology.

[6]  A. Gotto,et al.  ABCA1-Derived Nascent High-Density Lipoprotein–Apolipoprotein AI and Lipids Metabolically Segregate , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[7]  B. van de Sluis,et al.  News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1 , 2017, Current opinion in lipidology.

[8]  Xiaoke Yin,et al.  Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III , 2017, Journal of the American College of Cardiology.

[9]  Shailendra B. Patel,et al.  Evidence that the adenosine triphosphate‐binding cassette G5/G8‐independent pathway plays a determinant role in cholesterol gallstone formation in mice , 2016, Hepatology.

[10]  P. Kovanen,et al.  HDL functionality in reverse cholesterol transport--Challenges in translating data emerging from mouse models to human disease. , 2016, Biochimica et biophysica acta.

[11]  V. Fuster,et al.  Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus–Mediated Gene Transfer of Mutant hPCSK9 , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Phillips Molecular Mechanisms of Cellular Cholesterol Efflux* , 2014, The Journal of Biological Chemistry.

[13]  J. Heeren,et al.  High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice1[S] , 2014, Journal of Lipid Research.

[14]  C. Ballantyne,et al.  Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome. , 2013, Journal of clinical lipidology.

[15]  K. Moore,et al.  Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.

[16]  B. Pillot,et al.  Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1 , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[17]  M. Phillips,et al.  Serum albumin acts as a shuttle to enhance cholesterol efflux from cells[S] , 2013, Journal of Lipid Research.

[18]  H. Low,et al.  Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. , 2012, European heart journal.

[19]  M. Jauhiainen,et al.  The Cholesterol Content of Western Diets Plays a Major Role in the Paradoxical Increase in High-Density Lipoprotein Cholesterol and Upregulates the Macrophage Reverse Cholesterol Transport Pathway , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[20]  H. Kruth Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles , 2011, Current opinion in lipidology.

[21]  D. Rader,et al.  Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. , 2011, Gastroenterology.

[22]  A. Vaughan,et al.  Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux* , 2009, Journal of Lipid Research.

[23]  A. Guillaumet-Adkins,et al.  CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection. , 2008, Atherosclerosis.

[24]  D. Rader,et al.  Expression of Cholesteryl Ester Transfer Protein in Mice Promotes Macrophage Reverse Cholesterol Transport , 2007, Circulation.

[25]  H. Brewer,et al.  ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis* , 2006, Journal of Biological Chemistry.

[26]  Charles C Schwartz,et al.  Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.

[27]  A. Tall,et al.  ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Rigotti,et al.  The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. , 2003, Endocrine reviews.

[29]  A. Cooper,et al.  LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. , 2001, The Journal of clinical investigation.

[30]  F. Grosveld,et al.  Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Ala-Korpela,et al.  Modified LDL – trigger of atherosclerosis and inflammation in the arterial intima , 2000, Journal of internal medicine.

[32]  Robert V Farese,et al.  Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Nielsen,et al.  Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. , 1996, Atherosclerosis.

[34]  N. Maeda,et al.  The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Robert V Farese,et al.  Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). , 1993, The Journal of clinical investigation.

[36]  A. von Eckardstein,et al.  Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  M. Jauhiainen,et al.  Human plasma phospholipid transfer protein causes high density lipoprotein conversion. , 1993, The Journal of biological chemistry.

[38]  C. Fielding,et al.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.

[39]  M. Jauhiainen,et al.  Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism. , 1986, The Journal of biological chemistry.

[40]  S. Edge,et al.  Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects. , 1986, Biochimica et biophysica acta.

[41]  S. Eisenberg,et al.  High density lipoprotein metabolism. , 1984, Journal of lipid research.

[42]  M. Phillips,et al.  Kinetics and mechanism of free cholesterol exchange between human serum high- and low-density lipoproteins. , 1982, Biochemistry.

[43]  D. B. Zilversmit,et al.  A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. , 1981, The Journal of biological chemistry.

[44]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[45]  M. Brown,et al.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. H. Gregory,et al.  Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. , 1978, Science.

[47]  A. Gotto,et al.  Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability. , 2019, Methodist DeBakey cardiovascular journal.

[48]  A. Gotto,et al.  Cholesterol: Can't Live With It, Can't Live Without It. , 2019, Methodist DeBakey cardiovascular journal.

[49]  F. Blanco-Vaca,et al.  Quantification of In Vitro Macrophage Cholesterol Efflux and In Vivo Macrophage-Specific Reverse Cholesterol Transport. , 2015, Methods in molecular biology.